Japan Helps Bayer’s Eylea Sales To Sparkle
Strong Quarter For German Major
Executive Summary
Eye disease drugs have struggled to grow during the pandemic but Bayer's Regeneron-partnered blockbuster is going from strength to strength, helped by growth in Japan.